Changes of Bone Turnover Markers and Bone Mineral Density After Osteoporosis Treatment

NCT02156999 · Status: RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2021-09-21

No results posted yet for this study

Summary

To examine the changes of bone mineral density and bone turnover markers after Bonviva treatment in osteoporotic patients

Conditions

Interventions

DEVICE

Ibandronic acid, vitamin D

Sponsors & Collaborators

  • Shinshu University

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-06-30
Primary Completion
2022-10-31
Completion
2025-12-31

Countries

  • Japan

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02156999 on ClinicalTrials.gov